|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06826 HAOHAI BIOTEC
Nominal 
27.380 +0.740 (+2.778%) | 2025/06 - Interim RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Cash from / (used in) Operating Activities | -- | 648,572 | 634,450 | 231,296 | 342,286 |
| Net Cash from / (used in) Investing Activities | -- | 282,279 | (376,650) | (681,815) | (148,090) |
| Net Cash from / (used in) Financing Activities | -- | (390,345) | (257,727) | (288,350) | (231,251) |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 540,506 | 73 | (738,869) | (37,055) |
| Cash & Cash Equivalents at beginning of period | -- | 569,318 | 559,197 | 1,283,893 | 1,327,887 |
| Effect of Foreign Exchange Rate Changes | -- | 3,081 | 10,048 | 14,173 | (6,939) |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,112,905 | 569,318 | 559,197 | 1,283,893 |
| Remarks: | Real time quote last updated: 22/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 211,065 |
| %Change | -10.293% |
| EPS / (LPS) | RMB 0.910 |
| NBV Per Share (¥) | RMB 24.468 |